Fig. 8
From: PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma
A working model shows that targeting PKMYT1 ameliorates cisplatin sensitivity in OS by regulating the phosphorylation of NPM1. This figure was generated using the online tools of Biorender (https://app.biorender.com/)
